Effect of cholecystokinin on rectal motor and sensory function in patients with irritable bowel syndrome and healthy controls

Colorectal Disease

Volumn 15, Issue 1, 2013, Pages

  van der Schaar, P J ^a,b,c   van Hoboken, E ^c   Ludidi, S ^b   Masclee, A A M ^b,c  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Barostat; Irritable bowel syndrome; Rectal motility; Rectal sensitivity; Visceroperception

Indexed keywords

CHOLECYSTOKININ; PLACEBO;

ADULT; ARTICLE; BAROSTAT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTESTINE MUCOSA; IRRITABLE COLON; MALE; PAIN ASSESSMENT; PERCEPTION; POSTPRANDIAL STATE; PRESSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECTUM; SCORING SYSTEM; SENSORIMOTOR FUNCTION;

ADULT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHOLAGOGUES AND CHOLERETICS; CHOLECYSTOKININ; FEMALE; GASTROINTESTINAL MOTILITY; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; PRESSURE; PROSPECTIVE STUDIES; RECTUM; SENSATION; VISCERAL PAIN; YOUNG ADULT;

EID: 84871644000     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12034     Document Type: Article

References (25)

1. Wiley J, Tatum D, Keinath R, Owyang C. Participation of gastric mechanoreceptor and intestinal chemoreceptors in the gastrocolonic response. Gastroenterology 1988; 94: 1144-9.
2. Simren M, Abrahamsson H, Bjornsson ES. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut 2001; 48: 20-7.
3. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995; 109: 40-52.
4. Posserud I, Syrous A, Lindström L, Tack J, Abrahamsson H, Simrén M. Altered rectal perception in irritable bowel syndrome is associated with symptom severity. Gastroenterology 2007; 133: 11113-23.
5. Ludidi S, Conchillo JM, Keszthelyi D, van Avesaat M, Kruimel JW, Jonkers DM, Masclee AA. Rectal hypersensitivity as hallmark for irritable bowel syndrome: defining the optimal cutoff. Neurogastroenterol Motil 2012; 24: 729-33.
6. Simrén M, Agerforz P, Björnsson S, Abrahamsson H. Nutrient-dependent enhancement of rectal sensitivity in irritable bowel syndrome (IBS). Neurogastroenterol Motil 2007; 19: 20-9.
7. Simrén M, Abrahamsson H, Björnsson S. Lipid-induced colonic hypersensitivity in the irritable bowel syndrome: the role of bowel habit, sex and psychologic factors. Clin Gastroenterol Hepatol 2007; 5: 201-8.
8. Straathof JW, Mearadji B, Lamers CB, Masclee AA. Effect of CCK on proximal gastric motor function in humans. Am J Physiol 1998; 274(5 Pt 1): G939-44.
9. Feinle C, D'Amato M, Read NW. Cholecystokinin-A receptors modulate gastric sensory and motor responses to gastric distension and duodenal lipid. Gastroenterology 1996; 110: 1379-85.
10. van der Schaar PJ, Bremer Y, Lamers CB, masclee AA. Role of cholecystokinin in relaxation of the proximal stomach. Scand J Gastroenterol 2001; 36: 361-6.
11. Harvey RF, Read AE. Effect of cholecystokinin on colonic motility and symptoms in patients with the irritable bowel syndrome. Lancet 1973; 1: 1-3.
12. Renny A, Snape WJ, Sun EA, London R, Cohen S. Role of cholecystokinin in the gastrocolonic response to a fat meal. Gastroenterology 1983; 85: 17-21.
13. Niederau C, Faber S, Karaus M. Cholecystokinin's role in regulation of colonic motility in health and in irritable bowel syndrome. Gastroenterology 1992; 102: 1889-98.
14. Kellow JE, Miller LJ, Phillips SF, Haddad AC, Zinsmeister AR, Charboneu JW. Sensitivities of human jejunum, ileum, proximal colon, and gallbladder to cholecystokinin octapeptide. Am J Physiol 1987; 252: G345-56.
15. Coffin B, Fossati S, Flourie B et al. Regional effects of cholecystokinin octapeptide on colonic phasic and tonic motility in healthy humans. Am J Physiol 1999; 276: G767-72.
16. Enck P, Kaiser C, Felber M et al. Circaduin variation of rectal sensitivity and gastrointestinal peptides in healthy volunteers. Neurogastroenterol Motil 2009; 21: 52-8.
17. Lembo T, Munakata J, Mertz H et al. Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome. Gastroenterology 1994; 107: 1686-96.
18. Sabate JM, Coffin B, Jian R, Le Bars D, Bouhassira D. Rectal sensitivity assessed by a reflexologic technique: further evidence for two types of mechanoreceptors. Am J Physiol Gastrointest Liver Physiol 2000; 5: G692-9.
19. Jansen JB, Lamers CB. Molecular forms of cholecystokinin in human plasma during infusion of bombesin. Life Sci 1983; 33: 2197-205.
20. Lyrenas E, Abrahamsson H, Dotevall G. Failure of beta-adrenergic stimulation to affect cholecystokinin-stimulated sigmoid motility in man. Scand J Gastroenterol 1985; 20: 1169-74.
21. Sjolund K, Ekman R, Lindgren S, Rehfeld JF. Disturbed motilin and cholecystokinin release in the irritable bowel syndrome. Scand J Gastroenterol 1996; 31: 1110-4.
22. Roberts-Thompson IC, Fettman MJ, Jonsson JR, Frewin DB. Responses to cholecystokinin octapeptide in patients with functional abdominal pain syndromes. J Gastroenterol Hepatol 1992; 7: 293-7.
23. Whitehead WE, Holtkotter B, Enck P et al. Tolerance for rectosigmoid distension in irritable bowel syndrome. Gastroenterology 1990; 98: 1187-92.
24. ieverse RJ, Masclee AA, Janssen JB, Rovati LC, Lamers CB. Satiety effects of the type A CCK receptor antagonist loxiglumide in lean and obese women. Biol Psychiatry 1995; 37: 331-525.
25. Sabaté JM, Gorbatchef C, Flourié B, Jian R, Coffin B. Cholecystokinin octapeptide increases rectal sensitivity to pain in healthy subjects. Neurogastroenterol Motil 2002; 14: 689-95.